Early acid-reducing drug for kidney injury after severe bleeding
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving a common acid-reducing medication (a proton pump inhibitor, or PPI) early after severe bleeding from trauma can help protect the kidneys from injury. It compares this early treatment to usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have gone to the emergency room with severe bleeding from a traumatic injury.
- Your blood pressure was very low (systolic ≤ 90) and heart rate fast (≥ 108), or your systolic blood pressure was extremely low (≤ 70) upon arrival.
- You are not on dialysis or kidney replacement therapy.
- You do not have a known allergy to proton pump inhibitor medications (like omeprazole, pantoprazole, etc.).
- You are not pregnant and are not a prisoner.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a common stomach acid medication (a proton pump inhibitor) before, during, and after heart surgery can help prevent acute kidney injury. If you are at moderate to high risk for kidney problems after surgery, this study may be a good fit.
This trial tests two medicines that lower stomach acid to help stop bleeding from the stomach or intestines. It aims to find which one works better for people with this type of bleeding.
This trial tests if a newer acid-reducing drug is better than standard care for preventing stomach problems in people who recently had a heart attack and a stent placed. It could help those who need stomach protection while on blood thinners.
This trial compares a potassium-competitive acid blocker to a proton pump inhibitor to help prevent stomach or intestinal bleeding in people at high risk who take blood-thinning medicines. It may help reduce dangerous GI bleeding while you stay on heart/stroke medicines.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
This trial tests whether proton pump inhibitors (PPIs) can help people with cirrhosis who are hospitalized for variceal bleeding. It looks at whether PPIs reduce complications during the hospital stay.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.